You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

abemaciclib

Showing 51 - 75 of 137
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, GBM, Glioma Trial in Chandler, Phoenix, Scottsdale (Abemaciclib, LY3214996)

Recruiting
  • Glioblastoma
  • +2 more
  • Chandler, Arizona
  • +2 more
Mar 10, 2022

GBM, Glioblastoma, Brain Tumor Trial in Dallas (Abemaciclib, Bevacizumab)

Active, not recruiting
  • GBM
  • +3 more
  • Dallas, Texas
    UT Southwestern Medical Center
Jan 23, 2022

Renal Cell Carcinoma Metastatic Trial in Hershey (Abemaciclib, Sunitinib)

Active, not recruiting
  • Renal Cell Carcinoma Metastatic
  • Hershey, Pennsylvania
    Penn State Cancer Institute
Jan 5, 2022

Relapsed Solid Tumor, Refractory Solid Tumor Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)

Recruiting
  • Relapsed Solid Tumor
  • Refractory Solid Tumor
  • Abemaciclib
  • +4 more
  • Phoenix, Arizona
  • +28 more
Dec 7, 2022

Gastroesophageal Cancer, Adenocarcinoma Trial in United States (Pembrolizumab, Abemaciclib)

Active, not recruiting
  • Gastroesophageal Cancer
  • Adenocarcinoma
  • Indianapolis, Indiana
  • +3 more
Feb 16, 2022

Breast Cancer Trial in Poland, United States (ZN-c5, Abemaciclib)

Recruiting
  • Breast Cancer
  • Gilbert, Arizona
  • +6 more
Feb 14, 2022

Anatomic Stage IV Breast Cancer AJCC v8, HER2 Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Abemaciclib
  • Trastuzumab Emtansine
  • Yuma, Arizona
  • +5 more
May 25, 2022

Breast Cancer Trial (Giredestrant, Abemaciclib, Inavolisib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Feb 1, 2023

Breast Tumors, Tumor Metastasis Trial in India (Abemaciclib, Nonsteroidal Aromatase Inhibitor (NSAI), Fulvestrant)

Recruiting
  • Breast Neoplasms
  • Neoplasm Metastasis
  • Abemaciclib
  • +2 more
  • Hyderabad, Andhra Pradesh, India
  • +15 more
Aug 8, 2022

Breast Cancer, Metastasis Trial in New York (Abemaciclib, Bicalutamide)

Recruiting
  • Breast Cancer
  • Metastasis
  • New York, New York
  • +2 more
Oct 14, 2021

Tumors, Child, Adolescent Trial in Leiden (Ramucirumab, Cyclophosphamide, Vinorelbine)

Recruiting
  • Neoplasms
  • +2 more
  • Leiden, Netherlands
    Leids Universitair Medisch Centrum
Aug 14, 2023

Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in Los Angeles

Recruiting
  • Recurrent Endometrial Carcinoma
  • +3 more
  • Abemaciclib
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 28, 2021

Advanced Cancer Trial in Kashiwa, Yokohama (Abemaciclib, Abiraterone Acetate, Prednisolone)

Completed
  • Advanced Cancer
  • Abemaciclib
  • +2 more
  • Kashiwa, Chiba, Japan
  • +1 more
Sep 20, 2021

Non Small Cell Lung Cancer, Breast Cancer Trial in Worldwide (Abemaciclib, Pembrolizumab, Anastrozole)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Breast Cancer
  • Abemaciclib
  • +2 more
  • Fayetteville, Arkansas
  • +22 more
Aug 8, 2022

Breast Cancer Trial (Fluzoparib, Anastrozole, Letrozole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 5, 2023

Cancer Trial in Melbourne (Trametinib, Cobimetinib, Binimetinib)

Recruiting
  • Cancer
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Nov 4, 2022

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

Not yet recruiting
  • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
  • (no location specified)
Sep 26, 2023

Breast Cancer Female Trial in United Kingdom (Abemaciclib, Endocrine therapy)

Recruiting
  • Breast Cancer Female
  • Abemaciclib
  • Endocrine therapy (letrozole, anastrozole, exemestane or tamoxifen)
  • Truro, Cornwall, United Kingdom
  • +43 more
Jan 23, 2023

Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma Trial in Boston

Not yet recruiting
  • Male Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 12, 2022

Metastatic Esophageal Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Dallas (Abemaciclib,

Not yet recruiting
  • Metastatic Esophageal Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Dallas, Texas
    Baylor University Medical Center, Charles A Sammons Cancer Cente
Jun 4, 2021

Early Breast Cancer Trial in Spain (Doxorubicin, Cyclophosphamide, Taxane)

Active, not recruiting
  • Early Breast Cancer
  • Santiago De Compostela, A Coruña, Spain
  • +27 more
Jul 11, 2022

Endometrial Endometrioid Adenocarcinoma Trial in Chicago (Abemaciclib, Letrozole, Therapeutic Conventional Surgery)

Recruiting
  • Endometrial Endometrioid Adenocarcinoma
  • Abemaciclib
  • +2 more
  • Chicago, Illinois
  • +1 more
Apr 30, 2021

Sarcoma, Ewing, Tumor Metastasis Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)

Not yet recruiting
  • Sarcoma, Ewing
  • Neoplasm Metastasis
  • Abemaciclib
  • +2 more
  • Phoenix, Arizona
  • +29 more
Aug 17, 2022

Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

Not yet recruiting
  • Breast Cancer, Early Breast Cancer
  • (no location specified)
Jul 11, 2023

Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)

Active, not recruiting
Has Results
  • Breast Cancer
  • Abemaciclib
  • +4 more
  • Ijui, Rio Grande Do Sul, Brazil
  • +44 more
Aug 8, 2022